Davide Iacuaniello
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Journal: The journal of sexual medicine
Published: August 17, 2020
Approach to patients with pseudo-Cushing's states.
Journal: Endocrine connections
Published: November 29, 2019
The treatment with pasireotide in Cushing's disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single center.
Journal: Journal of endocrinological investigation
Published: January 12, 2018
Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess.
Journal: Frontiers of hormone research
Published: May 24, 2016
Erratum to: The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center.
Journal: Endocrine
Published: April 10, 2016
The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.
Journal: Endocrine
Published: December 16, 2015
Neuropsychiatric disorders in Cushing's syndrome.
Journal: Frontiers in neuroscience
Published: February 06, 2015
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center.
Journal: Endocrine
Published: October 22, 2014
Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas.
Journal: European journal of endocrinology
Published: July 05, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026